The purpose of this paper was to assess the potential effects associated with a cold ischemia time of up to 1 h at room temperature and the duration of frozen storage (-80°C) on the purity, quality, and amplificability of DNA isolated from colorectal tumor specimens.
Influence of Cold Ischemia Time and Storage Period on DNA Quality and Biomarker Research in Biobanked Colorectal Cancer Tissues
Pak MG, Roh MS
Purpose
Conclusion
DNA purity (ratio of absorbance at 260/280 nm, A260/280) was not affected by a cold ischemia time at room temperature of up to 1 h (1.80-1.90) or frozen storage of CRC tumor specimens at -80°C for up to 5 y (1.87-1.88). DNA from all CRC tumor specimens were considered to be of good quality; a crisp high molecular weight band was observed for all cold ischemia times and storage durations, and low molecular weight smears were not observed. Frozen CRC tumor specimens that experienced up to 1 h of cold ischemia time and were stored at -80°C for up to 5 y displayed 100% concordance in KRAS mutation status with case-matched formalin-fixed, paraffin-embedded (FFPE) specimens obtained and analyzed at the time of diagnosis.
Studies (1)
Purpose
The purpose of this paper was to assess the potential effects associated with a cold ischemia time of up to 1 h at room temperature and the duration of frozen storage on the quality and amplificability of DNA isolated from colorectal tumor specimens. In total, surgically resected colorectal tumor specimens from 45 patients with colorectal cancer were sectioned into 0.5 cm3 pieces and subjected to a cold ischemia time at room temperature of <30 min, 30-45 min, or 45-60 min, frozen at -80°C in cryovials; five specimens from each cold ischemia timepoint were then stored at -80°C for the following durations: <1 y, 2-3 y, 4-5 y. Prior to DNA extraction, frozen CRC tumor specimens were embedded in OCT, sectioned at a thickness of 5 µm, and then washed with PBS to remove the OCT compound. Sections were incubated in cell lysis buffer, treated with proteinase K (concentration and duration not specified), and DNA was extracted using the paramagnetic bead-based Maxwell 16 Viral Total Nucleic Acid Purification Kit. DNA purity was determined by NanoDrop spectrophotometry, and absorbance ratio (260/280 nm) thresholds were set at >1.8 (<1.8 was indicative of protein or phenol contamination) and <2.0 (> 2.0 was indicative of RNA contamination). DNA integrity was evaluated by gel electrophoresis. KRAS mutation (exon 2, codon 12 and 13) status was assayed by real-time PCR (CFX96 PCR detection system) with the PNAClamp KRAS Mutation Detection Kit. Cycle threshold (Ct) values were used to identify the presence of a KRAS mutation (ΔCt threshold = 2.0).
Summary of Findings
DNA purity was not affected by a cold ischemia time at room temperature of up to 1 h (1.80-1.90) or frozen storage of CRC tumor specimens at -80°C for up to 5 y (1.87-1.88); only one specimen (cold ischemia time, 31-45 min; frozen storage duration, 2-3 y) had a 260/280 ratio that fell outside of the thresholds specified (1.76). DNA from all CRC tumor specimens were considered of good quality; a crisp high molecular weight band was observed for all cold ischemia times and storage durations and low molecular weight smears were not observed. Frozen CRC tumor specimens that experienced up to 1 h of cold ischemia time and were stored at -80°C for up to 5 y displayed 100% concordance in KRAS mutation status with case-matched FFPE tumor specimens obtained and analyzed at the time of diagnosis.
Biospecimens
TissueColorectalPreservation Types
FrozenOCTDiagnoses
NeoplasticCarcinomaPlatforms
DNASpectrophotometryDNAReal-time qPCRDNAElectrophoresisPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Cold ischemia time 30-45 min45-60 min<30 minBiospecimen Preservation Type of fixation/preservation Formalin (buffered)FrozenStorage Storage duration 2-3 y4-5 y<1 yReal-time qPCR Specific Targeted nucleic acid KRAS